Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Growth, recognition, results—and an important partnership

Posted on January 17th, 2019 by in Pharma R&D

Here at Sigilon Therapeutics, we have had a very exciting period of growth recently, including receiving an Advanced Therapy Medicinal Product (ATMP) designation from the European Medicines Agency, adding two new members to our leadership team and initiating a collaboration with Eli Lilly in type 1 diabetes. Continue reading “Growth, recognition, results—and an important partnership” »

Emulating start-up success with purpose-built data tools

Posted on December 12th, 2018 by in Pharma R&D

Innovation used to be almost solely accredited to Big Pharma, but many of the more established businesses in the industry are finding that their rate of discovery is slowing as they try to find answers to some the industry’s biggest problems, such as antibiotic resistance. Continue reading “Emulating start-up success with purpose-built data tools” »

HIV Treatment: Dual Therapies and Dueling Companies

Posted on September 12th, 2016 by in Pharma R&D

After years of the AIDS epidemic taking a horrible toll on human life, some relief arrived in the 1990s as treatment for HIV, the virus that causes AIDS, came in the form of “cocktail” therapies that were developed by combining three or more antiretroviral drugs.

Continue reading “HIV Treatment: Dual Therapies and Dueling Companies” »